Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-02918-3.pdf
Reference45 articles.
1. Torre, L. A. et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians 65, 87–108, doi: 10.3322/caac.21262 (2015).
2. Gjertson, C. K. et al. Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era. Urology 70, 723–727, doi: 10.1016/j.urology.2007.05.014 (2007).
3. Ischia, J. & Gleave, M. Radical prostatectomy in high-risk prostate cancer. International journal of urology: official journal of the Japanese Urological Association 20, 290–300, doi: 10.1111/iju.12069 (2013).
4. Sailer, S. L. Radiation therapy for prostate cancer: external beam, brachytherapy, and salvage. North Carolina medical journal 67, 149–153 (2006).
5. Harris, W. P., Mostaghel, E. A., Nelson, P. S. & Montgomery, B. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion. Nature clinical practice. Urology 6, 76–85, doi: 10.1038/ncpuro1296 (2009).
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth;Journal of Clinical Investigation;2023-08-01
2. Myricetin alleviated hydrogen peroxide-induced cellular senescence of nucleus pulposus cell through regulating SERPINE1;Journal of Orthopaedic Surgery and Research;2023-02-27
3. CXCR7 as a novel therapeutic target for advanced prostate cancer;Oncogene;2023-02-09
4. Atypical chemokine receptors: emerging therapeutic targets in cancer;Trends in Pharmacological Sciences;2022-12
5. The power of heteronemin in cancers;Journal of Biomedical Science;2022-06-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3